Vaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Novavax logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photosaid on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
The trial, to be conducted in Australia, will enroll 640 healthy adults between the ages of 50 and 70 years and who have either been previously infected with the coronavirus or given an authorized COVID-19 vaccine at least eight weeks prior to the study. Participants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its Influenza shot NanoFlu along with an adjuvant or vaccine booster.
"Combination of these two vaccines...may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen," Gregory Glenn, President of Research and Development at Novavax, said in a statement. Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants. Its vaccine NanoFlu/NVX-CoV2373 had elicited robust responses to both influenza A and B and protected against the coronavirus in pre-clinical studies.Reporting by Mrinalika Roy in Bengaluru; Editing by Krishna Chandra EluriSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
White House push for COVID-19 vaccine booster shots may be premature, experts warnThe Biden administration has promised that come Sept. 20, anyone who wants a third dose of COVID-19 vaccine will be able to get one, as long as they are at least eight months past their second shot.
Leer más »
Peru to build plant to make Sputnik V COVID-19 vaccine - PresidentPeruvian President Pedro Castillo said on Monday that the government has reached an agreement with Russia to install a plant to produce the Sputnik V COVID-19 vaccine.
Leer más »
Peru to build plant to make Sputnik V COVID-19 vaccine - PresidentPeruvian President Pedro Castillo said on Monday that the government has reached an agreement with Russia to install a plant to produce the Sputnik V COVID-19 vaccine. Castillo did not provide further information on the timeline for the installation or production targets during a speech broadcast on national television, but added that the health minister would provide further information. Peru signed a contract to buy 20 million doses of Sputnik V in July.
Leer más »
COVID-19 live updates: 75% of American adults have had at least 1 vaccine doseLATEST: A Crisis Standards of Care plan has been enacted at 10 hospital systems in Idaho, which is only done as a 'last resort,' state health official says.
Leer más »
COVID-19 live updates: 3rd person dies in Japan after receiving contaminated Moderna vaccinePres. Biden on Thursday will deliver remarks on his plan to stop the spread of the delta variant and to boost vaccinations, the White House confirms.
Leer más »
Fauci on COVID-19 vaccine: ‘The optimal regimen will ultimately be that third shot’Anthony Fauci, President Joe Biden’s chief medical adviser, told NPR that a third booster shot will become the norm.
Leer más »